RPS 302 - Intra- and inter-reader agreement of diffusion‑weighted magnetic resonance imaging for breast cancer detection: a multi-reader study
04:46M. Montesano, Milan / Italy
2
RPS 302 - Dedicated axillary MRI-based radiomics analysis for the prediction of axillary lymph node metastasis in breast cancer
05:11R. Granzier, Maastricht / Netherlands
3
RPS 302 - Potential of MR lymphography for lymph nodes (LN) staging in breast cancer
05:04L. Alic, Enschede / Netherlands
4
RPS 302 - MRI-derived tumour-to-breast volume is associated with the extent of breast surgery
04:32A. Cozzi, Milan / Italy
5
RPS 302 - Towards contrast-free perfusion imaging in breast: feasibility of velocity-selective arterial spin labeling in breast cancer patients
05:32S. Franklin, Leiden / Netherlands
6
RPS 302 - Apparent diffusion coefficient mapping vs. the Kaiser score in the assessment of breast lesions: a multicentre comparison
05:18M. Dietzel, Erlangen / Germany
7
RPS 302 - The Kaiser score helps residents outperforming specialists in interpreting breast MRI
05:31N. Pötsch, Vienna / Austria
8
RPS 302 - Multidimensional diffusion MRI of breast tumours: initial findings
05:21I. Daimiel Naranjo, New York, NY / United States
9
RPS 302 - Positive MRI findings in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy
04:58S. Erdemli, Istanbul / Turkey
10
RPS 302 - Feasibility of computer-assisted triaging of MRI-guided biopsy in preoperative breast-cancer patients
04:25Hui Wang, Utrecht / Netherlands
11
RPS 302 - Breast MR biomarkers in benign and malignant tumours of the diseased and contralateral healthy breast
03:34K. Pinker-Domenig, New York, NY / United States
12
RPS 302 - Adding b2500 diffusion-weighted imaging to BI-RADS improves specificity of breast MRI
05:24L. Saccenti, Paris / France
13
RPS 302 - Evaluation of high-risk (B3) breast lesions on MRI: the role of conventional and texture analysis features in predicting upgrade to malignancy
04:59T. Aybal, Istanbul / Turkey
14
RPS 302 - Associations of non-contrast breast MRI biomarkers with benign and malignant breast tumours
05:13K. Pinker-Domenig, New York, NY / United States
15
RPS 302 - Feasibility study of 2D MR fingerprinting (MRF) of breast cancer
04:36E. Zanderigo, Aachen / Germany
16
RPS 302 - Background parenchymal enhancement on breast MRI in patients undergoing neoadjuvant chemotherapy: the association with tumour response and recurrence-free survival
05:42C. Costanza, Turin / Italy
17
RPS 302 - Preoperative staging in breast cancer: contrast-enhanced MRI vs digital breast tomosynthesis (DBT) evaluated together with unenhanced MRI (UE-MRI)
04:13V. Rizzo, Rome / Italy
18
RPS 302 - Comparison of 3 abbreviated breast MRI protocols in a screening population: a reader study
04:54I. Allajbeu, Cambridge / UK
PEP Subscription Required
This course is only accessible for ESR Premium Education Package subscribers.